Suna Kilic, 55, who lives in Tottenham, north London , was diagnosed with therapy-related leukaemia after undergoing intense ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

The Princess of Wales helped kick off the emir of Qatar’s trip to Britain on Tuesday as the U.K. government enlists one of ...

"The behaviours of some of the people in our organisation, particularly ... during Olivia's induction, were appalling," Simon ...

Some people naturally have higher levels of proteins that protect them from covid-19. New studies at Umeå University of our immune system may pave the way for more personalized treatments of both ...

Receiving a multiple sclerosis diagnosis can be daunting, but with the correct knowledge, support, and self-care, you can ...

ADIA Med will particularly explore the use of Mesenchymal Stem Cells (MSCs), especially from Umbilical Cord sources, for ...

In a recent article, researchers explored the use of Lytic Polysaccharide Monooxygenases (LPMOs) to enhance PETase activity ...

Monash University drug discovery researchers have found that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.

Drug discovery researchers have found that a natural fat molecule called 'lipoxin A4' (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.

LPX-TI641 is an oral novel Treg-expanding T cell/transmembrane, immunoglobulin, and mucin (Tim)receptor agonist therapy in development for the ...